Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

What is the Spike Protein and Why Are Mutations On It Important?

by Connor Bamford December 22, 2020, 12:11 pm
Human Spillover Potential of Reston Ebolavirus Noted by NIAID Study

by Global Biodefense Staff December 22, 2020, 10:23 am
Andes Virus: Outbreak Investigation Reveals Super-Spreader Potential

by Global Biodefense Staff December 7, 2020, 10:57 am
Demonstration of First Oral Drug to Rapidly Block SARS-CoV-2

by Global Biodefense Staff December 3, 2020, 4:27 pm
Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights

by Global Biodefense Staff December 3, 2020, 7:19 am
Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells

by Global Biodefense Staff December 2, 2020, 8:44 am
Tetracycline-based Antibiotics Show Promise for Combating Zika Infections

by Global Biodefense Staff November 25, 2020, 4:03 pm
Karolinska Institute Study Explains Important Cause of Fatal Influenza

by Global Biodefense Staff November 25, 2020, 2:26 pm
New Understanding of Neuropilin-1 Protein Could Speed Pandemic Vaccine Research

by Rajesh Khanna and Aubin Moutal November 18, 2020, 10:34 am
Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

by Global Biodefense Staff November 13, 2020, 1:11 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
DOE Providing Funding and Expertise for Researchers to Support COVID-19 Projects

by Global Biodefense Staff November 5, 2020, 8:15 pm
Stopping Zika Could Depend on Getting T Cells and Antibodies to Work Together

by Global Biodefense Staff November 4, 2020, 2:44 pm
Mayo Clinic Research Uses Web Search Analytics to Predict COVID Hotspots

by Global Biodefense Staff October 28, 2020, 6:18 am
Light Pollution May Increase Biting Behaviors of Disease-Spreading Mosquitoes

by Global Biodefense Staff October 28, 2020, 6:15 am

Congratulations. You've reached the end of the internet.

Research

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Novel Inhaled Vaccine for Tuberculosis Shows Strong Immune Response in Mice

Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

What is the Spike Protein and Why Are Mutations On It Important?

Human Spillover Potential of Reston Ebolavirus Noted by NIAID Study

Andes Virus: Outbreak Investigation Reveals Super-Spreader Potential

Demonstration of First Oral Drug to Rapidly Block SARS-CoV-2

Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights

Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells

Tetracycline-based Antibiotics Show Promise for Combating Zika Infections

Karolinska Institute Study Explains Important Cause of Fatal Influenza

New Understanding of Neuropilin-1 Protein Could Speed Pandemic Vaccine Research

Meet Ruby the Supercomputer: Now in Service for COVID-19 and Nuclear Security Research

DOE Providing Funding and Expertise for Researchers to Support COVID-19 Projects

Stopping Zika Could Depend on Getting T Cells and Antibodies to Work Together

Mayo Clinic Research Uses Web Search Analytics to Predict COVID Hotspots

Light Pollution May Increase Biting Behaviors of Disease-Spreading Mosquitoes

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles